Shortening the treatment of tuberculosis
- PMID: 15696148
- DOI: 10.1038/nbt0205-187
Shortening the treatment of tuberculosis
Similar articles
-
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.Science. 2005 Jan 14;307(5707):223-7. doi: 10.1126/science.1106753. Epub 2004 Dec 9. Science. 2005. PMID: 15591164 Clinical Trial.
-
Microbiology. TB--a new target, a new drug.Science. 2005 Jan 14;307(5707):214-5. doi: 10.1126/science.1108379. Science. 2005. PMID: 15653490 No abstract available.
-
Medicine. New TB drug promises shorter, simpler treatment.Science. 2004 Dec 10;306(5703):1872. doi: 10.1126/science.306.5703.1872. Science. 2004. PMID: 15591168 No abstract available.
-
[Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].Probl Tuberk. 2001;(6):48-9. Probl Tuberk. 2001. PMID: 11641963 Review. Russian. No abstract available.
-
Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.Pharmacotherapy. 2014 Nov;34(11):1187-97. doi: 10.1002/phar.1482. Epub 2014 Sep 9. Pharmacotherapy. 2014. PMID: 25203970 Review.
Cited by
-
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Antimicrob Agents Chemother. 2009 Mar;53(3):849-62. doi: 10.1128/AAC.00749-08. Epub 2008 Dec 15. Antimicrob Agents Chemother. 2009. PMID: 19075046 Free PMC article. Review. No abstract available.
-
Deletion of pknG Abates Reactivation of Latent Mycobacterium tuberculosis in Mice.Antimicrob Agents Chemother. 2021 Mar 18;65(4):e02095-20. doi: 10.1128/AAC.02095-20. Print 2021 Mar 18. Antimicrob Agents Chemother. 2021. PMID: 33468473 Free PMC article.
-
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.Antimicrob Agents Chemother. 2016 Jul 22;60(8):4778-85. doi: 10.1128/AAC.02548-15. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27216065 Free PMC article.
-
Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00190-18. doi: 10.1128/AAC.00190-18. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29661869 Free PMC article.
-
Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin.Clin Infect Dis. 2024 May 15;78(5):1246-1255. doi: 10.1093/cid/ciad700. Clin Infect Dis. 2024. PMID: 37982585 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical